SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.

Area of Science:

• Ophthalmology
• Ocular Surface Disease

Background:

• Dry eye disease (DED) is a prevalent condition affecting ocular comfort and vision.
• Punctal occlusion is a common treatment for DED, aiming to conserve natural tears.
• Conventional silicone punctal plugs are widely used, but their efficacy and complication rates vary.

Purpose of the Study:

• To compare the clinical efficacy, retention rates, and complications of SmartPlug versus silicone punctal plugs in patients with DED.
• To evaluate the impact of punctal occlusion on subjective symptoms, tear film stability, and ocular surface health.

Main Methods:

• A prospective randomized trial included 36 eyes with symptomatic DED and ocular surface damage.
• Eyes were randomized to receive either a silicone plug or a SmartPlug for inferior punctal occlusion.
• Pre- and post-treatment assessments included symptom scores, tear meniscus height, tear film breakup time (TBUT), Schirmer test, ocular staining, and artificial tear usage.

Main Results:

• Both plug types significantly improved symptom scores, TBUT, and ocular staining (P < 0.05).
• SmartPlug treatment led to a significant increase in tear meniscus height (P = 0.037), unlike silicone plugs.
• Artificial tear use decreased in over 55% of patients in both groups, with minor complications reported in 11-22%.

Conclusions:

• SmartPlug insertion demonstrates equivalent clinical efficacy to conventional silicone punctal plugs for DED management.
• Both SmartPlug and silicone plugs effectively reduce reliance on artificial tear supplements in a majority of DED patients.
• SmartPlug may offer additional benefits in improving tear volume, as indicated by tear meniscus height changes.